294 related articles for article (PubMed ID: 19729219)
21. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
22. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
[TBL] [Abstract][Full Text] [Related]
23. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
[TBL] [Abstract][Full Text] [Related]
24. Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study.
Çam H; Yılmaz N
Arab J Gastroenterol; 2020 Jun; 21(2):85-90. PubMed ID: 32423859
[TBL] [Abstract][Full Text] [Related]
25. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload.
Fernández-Ruiz M; Parra P; Ruiz-Merlo T; López-Medrano F; San Juan R; Polanco N; González E; Andrés A; Aguado JM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29120522
[TBL] [Abstract][Full Text] [Related]
26. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
[TBL] [Abstract][Full Text] [Related]
27. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
28. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
29. The effect of hepatitis B virus infection on hepcidin expression in hepatitis B patients.
Wang XH; Cheng PP; Jiang F; Jiao XY
Ann Clin Lab Sci; 2013; 43(2):126-34. PubMed ID: 23694786
[TBL] [Abstract][Full Text] [Related]
30. Duodenal ferroportin is up-regulated in patients with chronic hepatitis C.
Ma L; Zou T; Yuan Y; Lv J; Dong X; Yang G; Zhu Y; Luo J; Zhang Z; Yang J
PLoS One; 2014; 9(10):e110658. PubMed ID: 25330009
[TBL] [Abstract][Full Text] [Related]
31. Influence of esophageal variceal bleeding on iron status in chronic hepatitis C patients.
Abbas OM; Khalifa KAE; Makhlouf MM; Osman NF; Abdel Razek WM; Atta AS
Eur J Gastroenterol Hepatol; 2020 May; 32(5):616-622. PubMed ID: 31567713
[TBL] [Abstract][Full Text] [Related]
32. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
33. Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major.
Zaman BA; Rasool SO; Merza MA; Abdulah DM
Transfus Clin Biol; 2022 May; 29(2):153-160. PubMed ID: 34856399
[TBL] [Abstract][Full Text] [Related]
34. Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection.
Sikorska K; Romanowski T; Stalke P; Izycka Swieszewska E; Bielawski KP
Hepat Mon; 2014 Nov; 14(11):e21184. PubMed ID: 25598789
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
36. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
37. CHOP-mediated hepcidin suppression modulates hepatic iron load.
Mueller K; Sunami Y; Stuetzle M; Guldiken N; Kucukoglu O; Mueller S; Kulaksiz H; Schwarz P; Strnad P
J Pathol; 2013 Dec; 231(4):532-42. PubMed ID: 23749468
[TBL] [Abstract][Full Text] [Related]
38. Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.
Lee SH; Jeong SH; Park YS; Hwang JH; Kim JW; Kim N; Lee DH
Korean J Hepatol; 2010 Sep; 16(3):288-94. PubMed ID: 20924211
[TBL] [Abstract][Full Text] [Related]
39. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.
Huang X; Fung ET; Yip C; Zeleniuch-Jacquotte A
Blood Cells Mol Dis; 2008; 41(3):265-9. PubMed ID: 18694648
[TBL] [Abstract][Full Text] [Related]
40. Hepcidin levels in hereditary hyperferritinemia: Insights into the iron-sensing mechanism in hepatocytes.
Arnold J; Sangwaiya A; Manglam V; Thursz M; Beaumont C; Kannengiesser C; Busbridge M
World J Gastroenterol; 2010 Jul; 16(28):3541-5. PubMed ID: 20653062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
